SEC Form 4 · accession 0001209191-17-055109

MAGELLAN HEALTH INC · MGLN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP & Controller

Period of report

Oct 2, 2017

Accepted (ET)

Oct 3, 2017 · 4:26 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000019411

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Ordinary Common Stock, $0.01 par value	Oct 2, 2017	X	13,031	$49.10	A	26,962	D
Ordinary Common Stock, $0.01 par value	Oct 2, 2017	X	3,026	$47.46	A	29,988	D
Ordinary Common Stock, $0.01 par value	Oct 2, 2017	X	2,950	$53.00	A	32,938	D
Ordinary Common Stock, $0.01 par value^F2	Oct 2, 2017	S	19,007	$86.215	D	13,931	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F4,F3	$49.10	Oct 2, 2017	X	13,031	D	—	Mar 3, 2021	Common Stock	13,031	0	D
Stock Option (right to buy)^F4,F3	$47.46	Oct 2, 2017	X	3,026	D	—	Mar 5, 2022	Common Stock	3,026	15,601	D
Stock Option (right to buy)^F4,F3	$53.00	Oct 2, 2017	X	2,950	D	—	Mar 5, 2023	Common Stock	2,950	14,420	D

F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $85.50 to $86.70, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
F3All of the stock options in this tranche have vested in full.
F4Not applicable.